查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
双室注射器 (DCS) 灌装机的全球市场 - 2022-2029
市场调查报告书
商品编码
1140711

双室注射器 (DCS) 灌装机的全球市场 - 2022-2029

Global Dual Chamber Syringe (DCS) Filling Machine Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

双室注射器 (DCS) 灌装机市场规模预计将在 2021 年达到 3.267 亿美元，在 2029 年达到 5.081 亿美元，在预测期间（2022-2029 年）的复合年增长率为 7.9%，预计将在

双室注射器（DCS）灌装机是一种用于灌装双室注射器的设备。DCS 机器设计用于用液体或粉末药物的组合填充两室预填充注射器。这些机器主要用于工业药房和医院药房。

市场动态

市场增长受到各种因素的推动，例如注射器製造商的投资增加以及新技术的进步和采用新技术的改进。

预计科技进步和投资增加将推动市场增长。

全球双腔注射器灌装机市场的增长主要受到灌装机技术进步的推动。与传统的双腔注射器相比，新的双腔技术的更多采用提高了产品的可靠性、易用性和性能。隔离器和限制进入屏障系统 (RABS) 的引入提供了无菌製造环境，有效地将人工与填充和完成过程分开。填充和涂饰製造领域的几家领先设备製造商正在使用新的屏障隔离系统进行创新，这些集成式填充和涂饰机器可以执行填充和涂饰过程的所有阶段。另一方面，用于灌装和精整操作的传统设备既昂贵又耗时，使整个过程复杂化并且容易受到污染。传统的灌装机不銹钢系统需要额外的清洁和灭菌 (CIP/SIP)。另一方面，一次性系统通过消除复杂的灭菌步骤和简化批次末拆卸和去污，显着减少了转换时间。例如，DARA Pharmaceutical Packaging 展示了一款两室注射器灌装机。由于这些因素，一些生物製药公司正在其製药生产设施中安装这些机器。

此外，生物製药行业的增长和预充注射器製造商的投资增加也有望在预测期内推动市场增长。例如，Nipro Corporation 在德国和日本的工厂投资 1400 万美元，以扩大其预充式註射器的生产能力。该公司还在开髮用于治疗前列腺癌和乳腺癌患者的双腔预充式註射器。同样在 2022 年 10 月，生物製药行业注射给药技术的创新者 Credence Medsystems 获得了Bill & Melinda Gates Foundation的资助，用于 Credence 用于发展中国家的双室设计。注射器。因此，这种发展有望在未来几年为双腔注射器灌装机製造商创造机会。

技术系统和 RABS 的高成本预计将阻碍市场增长

隔离器和限制进入屏障系统 (RABS) 等新技术系统的高成本阻碍了双腔注射器灌装机市场的增长。限制访问屏障系统 (RABS) 和隔离器通常配备先进的功能，与传统系统相比，这些功能提高了价格。隔离器和 RABS 的平均成本为 4-8 百万美元，是传统系统的 5 倍。这使得预算有限的小型製药公司和研究机构很难购买此类设备。因此，在中国和印度等欠发达国家和发展中国家，目前隔离器和RABS的引入与传统系统相比非常低。

行业分析

全球双室注射器灌装机市场基于各种行业因素，如波特五力、监管分析、供应链分析、定价分析、技术趋势和进步、未满足的需求、COVID-19 的影响等。提供详细分析。

细分分析

自动化细分市场有望在全球双腔注射器（DCS）灌装机市场占据最大市场份额

全球双腔注射器灌装机市场分为手动、半自动和自动。其中，预计自动化部分将在预测期内占据双腔注射器 (DCS) 灌装机市场的最大份额。大型生产商对自动灌装机的需求不断增加，导致这一领域的增长。自动灌装机的人工参与较少，因此药物污染的可能性较小，因此被广泛采用。自动灌装机主要用于非处方药。

根据应用，市场分为医院药房、工业药房等。工业药房在 2022 年将主导双腔注射器灌装机市场，因为它们涉及药品的高生产、研究、包装、质量控制和销售。双室注射器有助于输送两种药物，以促进其在冻干可注射药物产品中的使用。製药行业一直希望采用患者可以自行给药的便捷产品。传统系统被小型製药和生物製药公司、研发实验室和学术机构广泛使用。

区域分析

北美在全球双腔注射器 (DCS) 灌装机市场中占有最大的市场份额。

由于注射器灌装机的技术发展，北美双室注射器灌装机在 2022 年占据了最大的市场份额，慢性病的上升导致对预灌装注射器的需求增加。根据乙型肝炎基金会的数据，每年有超过 80,000 名美国人感染乙型肝炎，据说大约有 200 万美国人患有慢性感染。在该地区，大多数製造商都获得了乙肝疫苗预装注射器的许可。例如，Dynavax 是获得 FDA 批准的预灌封注射器疫苗 HEPLISAV-B 的主要製药公司之一。在美国，预充式註射器将在接种疫苗方面发挥重要作用，因为在预测期内对 COVID-19 疫苗的需求将增加。注射器灌装机也取得了重大进展，推动了该地区的市场增长。例如，北卡罗来纳州阿什维尔的 Mission Health 安装了两个 ARxIUM RIV 自动 IV 分配系统，以无菌方式将液体和冻干产品填充 IV 注射器和袋子，以交付给 Mission Health 患者。我正在管理。其他开发包括优傲机器人 UR-3 机械臂，它执行注射器灌装和处理、小瓶灌装和处理、标记和验证、跟踪和跟踪以及唯一设备识别 (UDI)。这种情况进一步推动了市场。

另一方面，由于新兴国家的健康意识不断提高，对注射器灌装机的需求增加，以及增加医疗器械製造能力。然后估计。

竞争格局

由于少数主要参与者的存在，双室注射器 (DCS) 灌装机市场竞争相对激烈。为市场增长做出贡献的主要参与者包括 DARA Pharmaceutical、Syntegon Technology、Prosys Servo Filling Systems、TurboFil Packaging Machines 等。2022年，Bosch将旗下子公司之一Bosch Packaging Technology出售给CVC Capital Partners，并将其更名为Syntegon Technology。该公司是製药、生物製药和精细化学品、医疗器械和诊断、食品和糖果等多个行业的领先产品製造商。

领先公司正在采取多种增长战略，例如产品发布、收购和合作伙伴关係，这有助于双腔注射器 (DCS) 灌装机市场的全球增长。例如，2022 年 1 月，ProMach 产品品牌 NJM 在 Interphex 展位上推出了 Dara NFL/2-RDL 无菌灌装和封口机，用于使用 RayDyLyo 瓶盖的即用型小瓶。

值得关注的重点公司

Dara Pharma

概述 Dara Pharma 是生物技术、製药和化妆品行业的领先技术设备供应商。我们生产各种产品，例如小瓶、灌装机、灭菌器、旋盖机和半固体製剂。成立于 1996 年，总部位于巴塞罗那。

产品介绍

NFL/2-DC：双腔注射器灌装机，可用于填充和封盖药筒、小瓶和双腔注射器。

重大发展。2022 年 4 月，Dara Pharma 为药筒、注射器和小瓶设计了一种通用的交钥匙解决方案。

全球双室注射器 (DCS) 灌装机市场报告提供大约 45 多个市场数据表、40 多个数字，并由 180 页组成。

目录

第一章 调查方法和范围

  • 调查方法
  • 调查目的和范围

第二章市场定义和概述

第三章执行摘要

第四章市场动态

  • 市场影响因素
    • 促进者
      • 灌装机的技术进步
      • 注射器製造商扩大投资
    • 抑製剂
      • 隔离器成本高
      • 限制进入屏障系统 (RABS)
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 监管分析
  • 供应链分析
  • 定价分析
  • 技术趋势和进展
  • 未满足的需求
  • COVID-19 的影响

第 6 章 按类型

  • 手动的
  • 半自动
  • 自动的

第 7 章 按申请

  • 医院药房
  • 工业药品
  • 其他

第8章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东/非洲

第 9 章 竞争格局

  • 竞争情景
  • 市场/份额分析
  • 併购分析

第十章公司简介

  • Dara Pharmaceutical Packaging
    • 公司简介
    • 产品组合和描述
    • 主要发展状况
    • 财务概览
  • Syntegon Technology
  • Dymax Corporation
  • TurboFil Packaging Machine
  • Prosys Servo Filling Systems
  • Wenzhou Zhonguan Packaging Machinery
  • Optima Machinery Corporation
  • Shanghai Packaging Machinery
  • Inno4Life
  • Ashby Cross

第 11 章双室注射器 (DCS) 灌装机的全球市场-DataM

简介目录
Product Code: DMMDP2580

Market Overview

Dual Chamber Syringe (DCS) Filling Machine Market size was valued US$ 326.7 million in 2021 and is estimated to reach US$ 508.1 million by 2029, growing at a CAGR of 7.9% during the forecast period (2022-2029).

A dual-chamber syringe (DCS) filling machine is a device used for filling double-chamber syringes. The DCS machines are designed for filling dual chamber prefilled syringes with a combination of drugs which can either be liquid or powder. These machines are majorly used by industrial pharmacy and hospital pharmacy.

Market Dynamics

The market growth is driven by various factors such as growing investments by syringe manufactures and increasing novel technological advancements and enhancement in adoption of newer technologies.

Increasing novel scientific and technological advancement and growing investments are expected to drive market growth.

The global dual-chamber syringe filling machine market growth is majorly driven by the increasing technological advancements in filling machines. The increasing adoption of the newer dual-chamber technologies over the traditional dual-chamber syringe enhances the reliability, usability, and performance of the products. The introduction of isolators and restricted access barrier systems (RABS) creates a sterile manufacturing environment that can effectively separate the human operators from the fill-finish process. Several major device manufacturers in fill-finish manufacturing are innovating new barrier isolation systems, that are integrated fill-finish machines that can carry out all stages of fill-finish processes. On the other hand, the traditional equipment used in fill-finish operations is of high cost and time-consuming, which makes the entire process complex and prone to contamination. The conventional stainless-steel systems in traditional filling machines require additional cleaning and sterilization (CIP/SIP), whereas a single-use system eliminates the complex steps of sterilization and considerably reduces the change-over-time by simplifying end-of-batch breakdown and decontamination operations. For instance, DARA Pharmaceutical Packaging has introduced a dual-chamber syringe filling machine. Hence, owing to these factors, several biopharmaceutical companies are adopting these machines in drug production facilities.

Besides, the growing biopharmaceutical industry and rising investments by prefilled syringe manufacturers are also expected to drive the growth of the market during the forecast period. For instance, Nipro Corporation invested USD 14 million in its German and Japanese plants to expand the production capacity of prefilled syringes. The company is also developing dual chamber prefilled syringes for treating patients with prostate cancer and breast cancer. Also, in October 2022, Credence MedSystems, an innovator in injectable drug delivery technology for the biopharmaceutical industry, was awarded a grant from the Bill & Melinda Gates Foundation to support the development of Credence's Dual Chamber Reconstitution Syringe tailored for use in developing nations. Hence, these types of development are expected to create opportunities for dual-chamber syringe filling machine manufacturers in the coming years.

High cost of technological systems and RABS are expected to hamper the growth of market

The high cost of the new technological systems such as isolators and Restricted Access Barrier System (RABS) is hampering the growth of the dual-chamber syringe filling machine market. Restricted Access Barrier System (RABS) and isolators are well-equipped with advanced features which increases its price as compared to traditional systems. On average, isolators and RABS costs between US$ 4 million to US$ 8.0 million, which is five times that of traditional systems. Due to this, the accessibility is highly blocked for small pharma companies and research institutes that have a low budget for purchasing such equipment. Hence, the adoption of isolators and RABS is very low as compared to traditional systems in underdeveloped or developing countries, including China and India.

Industry Analysis

The global dual chamber syringe filling machine market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis, pricing analysis, technological trends and advancements, unmet needs, COVID-19 impact.

Segment Analysis

Automatic segment is expected to hold the largest market share in global dual chamber syringe (DCS) filling machine market

The global dual-chamber syringe filling machines are segmented into manual, semi-automatic, and automatic. Among these, the automatic segment is expected to gain maximum share during the forecast period in a dual-chamber syringe (DCS) filling machine market. The increasing demand for automatic filling machines by large-scale production companies is leading to the growth of this segment. The automatic filling machines have lower human involvement, which decreases the chances of drug contamination, hence are highly adopted. The automatic filling machines are mostly used for commercial drugs.

Based on applications, the market is classified into hospital pharmacy, industrial pharmacy, and others. The industry pharmacy is dominating the dual-chamber syringe filling machine market in 2022, as it involves high production, research, packaging, quality control, and sales of pharmaceutical products. The dual-chamber syringe helps in the delivery of two drugs to ease the use it is provided with lyophilized injectable drug products. The pharmaceutical industry always prefers to adopt convenient products to patients for self-administration. Traditional systems are still widely used in small pharma and biopharma companies, R&D laboratories, and academic institutes.

Geographical Analysis

North America region holds the largest market share in the global dual chamber syringe (DCS) filling machine market

North American dual-chamber syringe filling machines held the largest market share in 2022, owing to technological developments in the syringe filling machines, a rising number of chronic diseases which leads to more demand for prefilled syringes. According to the hepatitis B foundation, more than 80,000 Americans are infected with Hepatitis B annually, and around 2 million Americans are chronically infected. Most of the manufacturers are getting approval for prefilled syringes for Hepatitis B vaccines in this region. For instance, Dynavax was one of the major pharma companies to receive FDA approval for their prefilled syringe vaccine HEPLISAV-B. The prefilled syringes play an important role in the administration of the vaccine in the US as there is a rising demand for the COVID-19 vaccine over the forecast period. There have seen significant developments in the syringe filling machines which also drives the growth of the market in this region. For instance, NC-based Mission Health in Asheville installed two RIV automated IV compounding systems from ARxIUM that sterile-fill liquids and lyophilized products into IV syringes, and bags for administration to Mission Health patients. Also, there are developments, such as a Universal Robots UR-3 robotic arm to provide syringe filling and handling, vial filling and handling, mark and verify, track-and-trace, unique device identification (UDI) which further boosts the growth of the market.

On the other hand, the Asia-Pacific dual-chamber syringe (DCS) filling machine market is estimated to grow at the highest CAGR during the forecast period, owing to increased health awareness in developing countries, growing demand for syringe filling machines, and significant medical device manufacturing capacity.

Competitive Landscape

The Dual Chamber Syringe (DCS) Filling Machine market is moderately competitive with a few major players. Some of the key players which are contributing to the growth of the market are DARA Pharmaceutical, Syntegon Technology, Prosys Servo Filling Systems, TurboFil Packaging Machines, among others. In 2022, Bosch sold one of its subsidiaries, Bosch Packaging Technology, to CVC Capital Partners and was renamed Syntegon Technology. The company is a leading manufacturer of the product in several industries such as pharma, biopharma & fine chemicals, medical devices & diagnostics, food & confectionery, and other industries.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Dual Chamber Syringe (DCS) Filling Machine market globally. For instance, in January 2022, NJM, a ProMach product brand, introduced the Dara NFL/2-RDL aseptic filling and closing machine for ready-to-use vials utilizing the RayDyLyo cap at the Interphex booth.

Key Companies to Watch

Dara Pharmaceutical Equipment:

Overview: Dara Pharma is a company that provides advanced technological equipment to biotech, pharma and cosmetic industries. It manufactures variety of products such as vials, filling, sterilizing and closing machines, semi-solid products. It was founded in 1996 and is headquartered in Barcelona.

Product Portfolio:

NFL/2-DC: It is a dual chamber syringe filling machine that can be used for filling and closing of cartridges, vials and double chamber syringes.

Key Developments: In Apr 2022, Dara pharma designed a versatile turn key solutions for cartridges, syringes and vials.

The global dual chamber syringe (DCS) filling machine market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Technological advancements in filling machine
      • 4.1.1.2. Growing investments by syringe manufacturers
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of Isolators
      • 4.1.2.2. Restricted Access Barrier System (RABS)
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Regulatory Analysis
  • 5.3 Supply Chain Analysis
  • 5.4 Pricing Analysis
  • 5.5 Technological trends and advancements
  • 5.6 Unmet Needs
  • 5.7 COVID-19 Impact

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 6.1.2. Market Attractiveness Index, By Type Segment
  • 6.2. Manual
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Semi-automatic
  • 6.4. Automatic

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Hospital Pharmacy
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Industrial Pharmacy
  • 7.4. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. The U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. The U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. The Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. Dara Pharmaceutical Packaging
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Developments
    • 10.1.4. Financial Overview
  • 10.2. Syntegon Technology
  • 10.3. Dymax Corporation
  • 10.4. TurboFil Packaging Machine
  • 10.5. Prosys Servo Filling Systems
  • 10.6. Wenzhou Zhonguan Packaging Machinery
  • 10.7. Optima Machinery Corporation
  • 10.8. Shanghai Packaging Machinery
  • 10.9. Inno4Life
  • 10.10. Ashby Cross

LIST NOT EXHAUSTIVE

11. Global Dual Chamber Syringe (DCS) Filling Machine Market - DataM

  • 11.1. Appendix
  • 11.2. About Us and Method of Fixation
  • 11.3. Contact Us